FORMULATION DEVELOPMENT AND EVALUATION OF DILTIAZEM HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLET.

Journal Title: Indo American Journal of Pharmaceutical Research - Year 2017, Vol 7, Issue

Abstract

Abstract The aim of the current study was to design sustained release tablet of Diltiazem hydrochloride and to optimize the drug release profile and dissolution time using response surface methodology. Diltiazem hydrochloride is an antihypertensive drug, a benzothiazepine derivative with vasodilating action. It is prescribed for the treatment of hypertension and other cardiovascular disorder. Antihypertensive should continue for several months. Diltiazem hydrochloride has half-life of 3-4.5 hours. So its chronic use necessitates the sustained release formulation to reduce dose and dosing frequency. A 32 full factorial design (2 factors at 3 levels each) was employed to systematically optimize the drug release profile. Kollidon SR and HPMC K100 were taken as the independent variables. The % drug release at 4 hr and % drug release at 24 hr were dependent variables .Tablets were prepared by direct compression and evaluated for Hardness, Friability, Percent drug content and In-vitro drug release pattern. Both the polymers had significant effect on the drug release and of the tablets. All the formulation release the drug for more than 24 hours. The optimized formulation F6 having Kollidon SR 135mg and HPMC K100 105mg showed maximum release of 98.70 % drug release for 24 hr. Most of the formulation followed Higuchi Model.so sustained release tablet of diltiazem HCl was formed which provide drug release for 24 Hrs.

Authors and Affiliations

D V Derle1, R S Barhate1*, P A Umberkar1, N D Derle2

Keywords

Related Articles

DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING RP-UPLC METHOD FOR THE SIMULTANEOUS QUANTIFICATION OF SOFOSBUVIR AND VELPATASVIR IN FINISHED DOSAGE FORM

A simple, rapid, accurate, precise and economical reverse phase Ultra performance liquid chromatographic method was developed for simultaneous quantification of two anti-viral drugs, viz., Sofosbuvir and Velpatasvir. The...

PREVALENCE OF MENTAL RETARDATION IN CHILDREN WITH ADHD, AN EPIDEMIOLOGICAL STUDY, AT SIR C.J.INSTITUTE OF PSYCHIATRY, HYDERABAD

Objectives: To determine the frequency of Mental retardation in children of attention deficit hyperactivity disorder. Study Design: A Cross-Sectional Study. Patient and Method: Study was conducted in the outpatient depar...

A STUDY OF PATTERN OF REFERRALS IN LIAISON PSYCHIATRY

Abstract Liaison psychiatry specializes in bridging psychiatric services to other specialities. It has been actively intervening in the reduction of the communication gap between the various specialities in many health c...

A PHARMACOLOGICAL PROMISE TOWARDS CELL CYCLE TARGET INHIBITION IN ANTICANCER DRUG DISCOVERY OF ULVAN ISOLATED FROM Ulva lactuca(L).

Abstract Objective: To prescreen the in vivo antiproliferative activity of the marine green alga Ulva lactuca Family Ulvaceae using the eukaryotic model organism Dictyostelium discoideum. Method: In the present study to...

PRESCRIBERS� ADHERENCE TO THE BASIC PRINCIPLES OF PRESCRIPTION ORDER WRITING IN A TEACHING HOSPITAL, ETHIOPIA

12 PRESCRIBERS� ADHERENCE TO THE BASIC PRINCIPLES OF PRESCRIPTION ORDER WRITING IN A TEACHING HOSPITAL, ETHIOPIA Teshale Ayele1, Tessema Tsehay2, Haymanot Bedada2 1Department of Pharmacy, Institute of Health Sciences,...

Download PDF file
  • EP ID EP330698
  • DOI -
  • Views 93
  • Downloads 0

How To Cite

D V Derle1, R S Barhate1*, P A Umberkar1, N D Derle2 (2017). FORMULATION DEVELOPMENT AND EVALUATION OF DILTIAZEM HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLET.. Indo American Journal of Pharmaceutical Research, 7(), -. https://europub.co.uk/articles/-A-330698